Assay ID | Title | Year | Journal | Article |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 ISSN: 1464-3405 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 ISSN: 1872-9096 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 ISSN: 1552-454X | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
ethoxzolamide | | aromatic ether; benzothiazoles; sulfonamide | antiglaucoma drug; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
riluzole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tiaramide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ticlatone | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzothiazole | | benzothiazoles | environmental contaminant; plant metabolite; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dibenzothiazyl disulfide | | benzothiazoles; organic disulfide | allergen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-aminobenzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diamthazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dithiazanine | | benzothiazoles; benzothiazolium ion | anthelminthic drug; fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(methylthio)benzothiazole | | benzothiazoles; methyl sulfide | aryl hydrocarbon receptor agonist; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-hydroxyphenyl)benzothiazole | | benzothiazoles; phenols | geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methabenzthiazuron | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sabeluzole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lubeluzole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-benzothiazolesulfonamide | | benzothiazoles; sulfonamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tioxidazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-Morpholinyl)benzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mefenacet | | benzothiazoles; tertiary carboxamide | antimitotic; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
firefly luciferin | | 1,3-thiazolemonocarboxylic acid; benzothiazoles; imidothioate | luciferin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pramipexole | | benzothiazoles; diamine | antidyskinesia agent; antiparkinson drug; dopamine agonist; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-methoxyphenyl)-1,3-benzothiazol-2-amine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-pyridin-4-yl-1,3-benzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-methoxy-3-methyl-1,3-benzothiazol-2-imine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-Fluoro-1,3-benzothiazol-2-amine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(1-azepanyl)-1,3-benzothiazol-6-yl]carbamic acid ethyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
e 3040 | | benzothiazoles; organic hydroxy compound; pyridines; secondary amino compound | anti-inflammatory drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; uricosuric drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
E3040 glucuronide | | benzothiazoles; beta-D-glucosiduronic acid; pyridines; secondary amino compound | xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(3,5-dimethyl-1-pyrazolyl)-1,2-benzothiazole 1,1-dioxide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-ethoxy-2-[(4-fluorophenyl)methylthio]-1,3-benzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-propan-2-yl-1,3-benzothiazol-2-amine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(2-phenoxyethyl)-1,3-benzothiazol-2-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[3-(2-methoxyphenoxy)propyl]-1,3-benzothiazol-2-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-oxo-1,3-benzothiazol-3-yl)-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1,3-benzothiazol-2-yl)-N-methylbenzamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(1-cyclohexyl-5-tetrazolyl)thio]-N-(6-ethoxy-1,3-benzothiazol-2-yl)acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(1,3-benzothiazol-2-yl)-3-methyl-2-butenenitrile | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(4-chloro-1-pyrazolyl)methyl]-N-(6-methyl-1,3-benzothiazol-2-yl)-2-furancarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-furanylmethyl)-2-(2-oxo-1,3-benzothiazol-3-yl)acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-ethoxy-1,3-benzothiazol-2-yl)-2-methoxyacetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-methoxy-1,3-benzothiazol-2-yl)-3-methylbutanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4,5-dihydrothiazol-2-ylthio)-N-(6-methoxy-1,3-benzothiazol-2-yl)acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(beta-D-glucosyl)benzothiazole | | benzothiazoles; C-glycosyl compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[(1,3-benzothiazol-2-ylthio)methyl]-2-azepanone | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[3-[4-(dimethylamino)phenyl]-4,5-dihydroisoxazol-5-yl]methyl]-1,1-dioxo-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(1,3-benzothiazol-2-ylthio)methyl]-2-furancarboxylic acid methyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4,6-dimethyl-2-pyrimidinyl)-1,3-benzothiazol-2-amine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
captax | | aryl thiol; benzothiazoles | carcinogenic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-benzothiazol-2-yl(thiomorpholin-4-yl)methanone | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[[(6-methyl-1,3-benzothiazol-2-yl)amino]-sulfanylidenemethyl]-2-thiophenecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(1,3-benzothiazol-2-ylmethoxy)phenol | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(1-cyclohexenyl)ethyl]-3-(2-oxo-1,3-benzothiazol-3-yl)propanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-methyl-2-thiazolyl)-3-(2-oxo-1,3-benzothiazol-3-yl)propanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1,3-benzothiazol-2-yl)-2-cyclohexylacetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-phenyl-1,3-benzothiazol-2-ylidene)-2-propenamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-methoxyphenyl)-3-methyl-1,3-benzothiazol-2-imine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-ethoxy-1,3-benzothiazol-2-yl)butanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[[(6-methoxy-1,3-benzothiazol-2-yl)amino]-sulfanylidenemethyl]-2-furancarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-chlorophenyl)methylthio]-6-nitro-1,3-benzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1,3-benzothiazol-2-yl)-2-[(1-methyl-2-imidazolyl)thio]acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4,6-bis(4-morpholinyl)-1,3,5-triazin-2-yl]-2-(methylthio)-1,3-benzothiazol-6-amine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[cyclohexyl(oxo)methyl]amino]-1,3-benzothiazole-6-carboxylic acid methyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methyl-1,3-benzothiazol-6-yl)-2-furancarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2,4,5-trimethoxyphenyl)-1,3-benzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[2-(3-methylphenoxy)ethyl]-1,3-benzothiazol-2-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[2-(4-methylphenoxy)ethyl]-1,3-benzothiazol-2-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methoxy-N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)benzamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-ethoxy-1,3-benzothiazol-2-yl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[6-(diethylsulfamoyl)-1,3-benzothiazol-2-yl]-2-thiophenecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(3-bromo-2-imidazo[1,2-a]pyrimidinyl)methylthio]-1,3-benzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-chloro-1,3-benzothiazol-2-yl)-2-diphenylphosphorylacetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(1,3-benzothiazol-2-ylthio)methyl]-4-cyclohexyl-1H-1,2,4-triazole-5-thione | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-fluoro-2-phenyl-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-fluoro-2-(2-methylphenyl)-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[[2-(1,3-benzothiazol-2-ylthio)-1-oxoethyl]amino]-3-phenylthiourea | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-[(1,3-benzothiazol-2-ylthio)methyl]-4-triazolecarboxylic acid methyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-methoxy-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]-[(1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]cyanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-chloro-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]-[(1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]cyanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(4,7-dichloro-1,3-benzothiazol-2-yl)hydrazine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4,5-trimethoxy-N-(3-methyl-1,3-benzothiazol-2-ylidene)benzamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(1,3-benzothiazol-2-ylthio)butanoic acid [2-[(3-cyano-2-thiophenyl)amino]-2-oxoethyl] ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(1,3-benzothiazol-2-ylthio)-1-oxoethyl]-1-methyl-2-pyrrolecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(1,3-benzothiazol-2-yl)propanoic acid (3,5-dimethyl-4-isoxazolyl)methyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(1,3-benzothiazol-2-yl)-3-propylurea | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-bromo-N-(6-sulfamoyl-1,3-benzothiazol-2-yl)-2-furancarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4,7-dimethoxy-3-methyl-1,3-benzothiazol-2-ylidene)butanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-fluoro-3-methyl-1,3-benzothiazol-2-ylidene)-2-nitrobenzamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-bromo-N-(4,7-dimethoxy-1,3-benzothiazol-2-yl)-2-thiophenecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(methylthio)-1,3-benzothiazol-6-yl]-2-furancarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-cyclohexyl-3-(6-ethoxy-1,3-benzothiazol-2-yl)urea | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-bromo-N-(4-methoxy-1,3-benzothiazol-2-yl)-2-thiophenecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(1,3-benzothiazol-2-yl)-5-methyl-3-pyrazolamine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl(oxo)methyl]-1,1-dioxo-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-4-oxo-4-thiophen-2-ylbutanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-phenylethyl)-1,3-benzothiazol-2-amine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4,5,6-trifluoro-1,3-benzothiazol-2-yl)-2-furancarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[5-(1,3-benzothiazol-2-yl)-2-thiophenyl]-oxomethyl]-1-piperazinecarboxaldehyde | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-benzothiazole-6-carboxylic acid (2-benzamido-2-oxoethyl) ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-benzothiazole-6-carboxylic acid [2-[(3,5-dichloro-4-methyl-2-pyridinyl)amino]-2-oxoethyl] ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-benzothiazole-6-carboxylic acid [2-(2-furanyl)-2-oxoethyl] ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(1,1-dioxo-1,2-benzothiazol-3-yl)-N-(2-methylphenyl)-4-piperidinecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methyl-1,3-benzothiazol-6-yl)benzamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-chloro-3-pyridinyl)-1,3-benzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-[(1,3-benzothiazol-2-ylthio)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-[2-(4-morpholinyl)ethyl]acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[6-(dimethylsulfamoyl)-1,3-benzothiazol-2-yl]-2-thiophenecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-benzothiazole-6-carboxylic acid [2-[1-(1-methoxypropan-2-yl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-methyl-1,3-benzothiazol-2-ylidene)-2-pyrazinecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(6-imidazo[2,1-b]thiazolyl)acetic acid [2-(1,3-benzothiazol-2-ylamino)-2-oxoethyl] ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1,3-benzothiazol-2-yl)-2-oxolanecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-furanylmethyl)-N-[2-(methylthio)-1,3-benzothiazol-6-yl]-5-oxo-3-pyrrolidinecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-thiophen-2-ylsulfonyl-4-piperidinecarboxylic acid 1,3-benzothiazol-2-ylmethyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1,3-benzothiazol-2-yl)-2-methoxy-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]benzamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[2-(4-methyl-1-piperidinyl)-1,3-benzothiazol-6-yl]-oxomethyl]-1-piperazinecarboxylic acid ethyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(6-fluoro-1,3-benzothiazol-2-yl)amino]-4-thiazolecarboxylic acid ethyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(4,6-difluoro-1,3-benzothiazol-2-yl)morpholine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-bromo-2-thiophenecarboxylic acid 1,3-benzothiazol-2-ylmethyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-acetamido-3-prop-2-enyl-1,3-benzothiazol-2-ylidene)cyclohexanecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-acetamido-3-prop-2-enyl-1,3-benzothiazol-2-ylidene)-2-thiophenecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloro-N-(3-methyl-1,3-benzothiazol-2-ylidene)acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(1,3-benzothiazol-2-ylmethylthio)-1-butyl-5-benzimidazolesulfonamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-phenyl-1,3,4-oxadiazol-2-yl)-1,3-benzothiazole-2-carboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methoxy-N-(3-methyl-6-methylsulfonyl-1,3-benzothiazol-2-ylidene)benzamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-(butan-2-ylamino)-6-chloro-1,3,5-triazin-2-yl]-[(1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]cyanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(2-methoxyethyl)-6-methylsulfonyl-1,3-benzothiazol-2-ylidene]-2-nitrobenzamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-(4,6-difluoro-1,3-benzothiazol-2-yl)benzohydrazide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-N-[3-(2-methoxyethyl)-6-sulfamoyl-1,3-benzothiazol-2-ylidene]-1-benzothiophene-2-carboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(7-methyl-2-thiazolo[4,5-g][1,3]benzothiazolyl)propanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(2-methylcyclohexyl)-2,4-dihydro-1H-1,3,5-triazin-6-yl]-1,3-benzothiazol-2-amine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-fluoro-1,3-benzothiazol-2-yl)-2-oxolanecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-methyl-1,3-benzothiazol-2-yl)-6-oxo-1-phenyl-4,5-dihydropyridazine-3-carboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[1-(6-ethoxy-1,3-benzothiazol-2-yl)-3-piperidinyl]-oxomethyl]-1-piperazinecarboxylic acid ethyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-methyl-5-[(2-oxo-1,3-benzothiazol-3-yl)methyl]-1,2,4-triazol-3-yl]thio]-N-(phenylmethyl)acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-oxolanylmethyl)-2-(1-piperidinyl)-1,3-benzothiazole-6-carboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-methyl-1,3-benzothiazol-2-yl)-2-(5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-2-yl)acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-methyl-1,3-benzothiazol-2-yl)-2-(1-pyrrolyl)acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dithiazanine iodide | | benzothiazoles; organic iodide salt | anthelminthic drug; fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,3'-diethylthiacarbocyanine iodide | | benzothiazoles; cyanine dye | fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tyrphostin ag825 | | aromatic ether; benzothiazoles; enamide; nitrile; organic sulfide; phenols; primary carboxamide | epidermal growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(1,3-benzothiazol-2-yl)-4-chloro-5-(3-chloroanilino)-3-pyridazinone | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(6-methoxy-1,3-benzothiazol-2-yl)amino]-3-methyl-2-thiophenecarboxylic acid ethyl ester | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-fluoro-N-phenyl-1,3-benzothiazol-2-amine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-(4-fluoro-1,3-benzothiazol-2-yl)-2-phenoxyacetohydrazide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-(4,5-dimethyl-1,3-benzothiazol-2-yl)propanehydrazide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-(4,6-difluoro-1,3-benzothiazol-2-yl)propanehydrazide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-fluoro-N-(4-fluoro-1,3-benzothiazol-2-yl)-1,3-benzothiazol-2-amine | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(dimethylamino)propyl]-N-(6-methyl-1,3-benzothiazol-2-yl)-1,3-benzothiazole-6-carboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3,5-dimethyl-1H-pyrrol-2-yl)-1,3-benzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-methoxy-1,3-benzothiazol-2-yl)-1-thiophen-2-ylsulfonyl-4-piperidinecarboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
r 115866 | | aromatic amine; benzothiazoles; secondary amino compound; triazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
as 601245 | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-methoxyphenyl)-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenyl)-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tozadenant | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(benzenesulfonyl)-N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]propanamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-fluorophenyl)-6-methoxy-1,3-benzothiazole | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3-chlorophenyl)-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vizamyl | | (18)F radiopharmaceutical; aromatic amine; benzothiazoles; secondary amino compound | radioactive imaging agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
picogreen | | benzothiazoles; cyanine dye; quinolines; tertiary amine | fluorescent dye | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,3'-diethylthiacarbocyanine iodide | | benzothiazoles; cyanine dye | fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(3,5-dimethyl-1-piperidinyl)propyl]-2-(1-piperidinyl)-1,3-benzothiazole-6-carboxamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-fluoro-2-phenyl-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-fluorophenyl)-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-fluorophenyl)-1,2-benzothiazol-3-one | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
INDY | | benzothiazoles; enone; organic hydroxy compound | antineoplastic agent; drug metabolite; EC 2.7.12.1 (dual-specificity kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3-oxo-1,2-benzothiazol-2-yl)-N-phenylacetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tak-632 | | (trifluoromethyl)benzenes; aromatic ether; benzothiazoles; cyclopropylcarboxamide; monofluorobenzenes; nitrile; secondary carboxamide | antineoplastic agent; apoptosis inducer; B-Raf inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor; necroptosis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(1,3-benzothiazol-2-yl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-2-yl]acetamide | | benzothiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ML355 | | benzothiazoles; monomethoxybenzene; phenols; secondary amino compound; substituted aniline; sulfonamide | EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dehydroluciferin | | 1,3-thiazolemonocarboxylic acid; benzothiazoles; biaryl; phenols | animal metabolite; luciferin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |